Awarded
Vacunas inactivadasa producidas a partir de virus crecidos en cultivos celulares de virus fraccionados o de antígenos de superficie (H y N), o análogas, de 15 microgramos de hemaglutinina de cada cepa incluida en la vacuna.
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- SEQIRUS SPAIN S.L.
- Contract value
- €5,005
- Bids received
- 1
- Published
- 29 Sept 2025
- Awarded
- 23 Sept 2025
- Contract start
- 23 Sept 2025
- Contract end
- 24 Sept 2026estimated
- Region
- Valladolid